Vivos Therapeutics secures nearly $4M to support medical technology solutions

Vivos Therapeutics (NASDAQ:VVOS) is set to raise approximately $4 million through a private placement offering. The company will issue 980,393 shares to an institutional investor at a price of $4.08 per share. Additionally, the investor will receive a five-year Series A Warrant to purchase up to the same number of common stock shares and an 18-month Series B Warrant for the same number of shares, each with an exercise price of $3.83 per share. The private placement is expected to close around November 2, 2023. Vivos plans to utilize the net proceeds for general corporate purposes.